|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Abnormal lipid and apolipoprotein composition of major lipoprotein densi ty classes in patients with chronic renal failure显示文摘 | Attman PO Alaupovic P Tavella M | 1996 | Neph rol Dial Transplant1996，11，1： | 1 |
| 2 | Lipid and apolip0protein profiles of uremic dyslipoproteinemia-relation to renal function and dialysis 显示文摘 | Attman P O Alaupovic P | 1991 | Nephron1991，57，4： | 1 |
| 3 | Lipid and apolipoprotein profiles of uremic dyslipoproteinemia-relation to renal function and dialysis显示文摘 | Attman PO Alaupovic P | 1991 | Nephron1991，57，4： | 1 |
| 4 | Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease显示文摘 | Attman P Alaupovic P Samuelsson O | 1999 | Kidney Int1999，56，71： | 1 |
| 5 | The effects of varying doses of Ton insulin sensitivity,plasma lipids,apolipoproteins,and C-reactive protein in healthy young men显示文摘 | Singh AB Hsia S Alaupovic P | 2009 | J Clin Endocrinol Metab2009，8，7： | 1 |
| 6 | Metabolic outcome during I year in newly detected hypertensives:results of the Anti hypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation(ALPINE study)显示文摘 | Lindholm LH Persson M Alaupovic P | 2003 | J Hypertens2003，21，8： | 1 |
| 7 | The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesion as determined by sequential coronary angiography from a controlled clinic trial显示文摘 | Alaupovic P Mack WJ Knight-Gibson C Hodis HV | 1997 | Arterioscler Thromb Vasc Biol1997，17，： | 1 |
| 8 | Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with el- evated serum cholesterol and triglyceride levels显示文摘 | Alaupovic P Heinonen T Shurzinske L | 1997 | Ather- osclerosis1997，133，1： | 1 |
| 9 | Lipid and apolipoprotein profiles of uremic dyslipoproteinemia-relation to renal function and dialysis显示文摘 | Attman PO Alaupovic P | 1991 | Nephron1991，57，4： | 1 |
| 10 | Lipop rotein metabo- lismandrenal failure显示文摘 | Attman P O Samuelsson O Alaupovic P | 1993 | Am J Kidney Dis1993，21，： | 1 |
| 11 | Lipoprotein abnorma lities as a risk factor for progressive nondiabetic renal disease显示文摘 | Attman P Alaupovic P Samuelsson O | 1999 | Kidney Int1999，56，71： | 1 |
| 12 | Lipoprotein abnormalities as arisk factor for progressive no diabetic renal disease 显示文摘 | Attman PO Alaupovic P Ssmuelsson O | 1999 | Kidney Int Suppl1999，71，： | 1 |
| 13 | Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)显示文摘 | LINDHOLM LH PERSSON M ALAUPOVIC P et ol | 2003 | J Hypertens2003，21，8： | 1 |
| 14 | Diagnosis and classification of dyslipidemia in renal disease显示文摘 | Attman PO Samuelsson O Alaupovic P | 1996 | Blood Purif1996，14，1： | 1 |
| 15 | The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men 显示文摘 | Singh AB Hsia S Alaupovic P | 2003 | J Clin Endocrinol Metab2003，87，： | 1 |
| 16 | Lipoprotein metabolism and renal failure显示文摘 | Attman PO Samuelsson O Alaupovic P | 1999 | Am J Kidney Dis1999，1，： | 1 |
| 17 | Effects of saturated,monounsaturated,and ω-6 polyunsaturated fatty acids on plasma lipids,lipoproteins,and apoproteins in humans显示文摘 | Becker N Illingworth DR Alaupovic P Connor WE Sundberg EE | | 0，，03： | 1 |
| 18 | VLDL, apoli- poproteins B, C I~ and E and risk of recurrent coronary e- vents in the Cholesterol and Recurrent Events (CARE) trial显示文摘 | Sacks FM Alaupovic P Moye LA | 2000 | Circulation2000，102，： | 1 |
| 19 | Binding and degradtion of human high- density lipoprotein by human hepatoma cell line HepC2显示文摘 | Dashfi N Wolfbauer Alaupovic P | 1985 | Bioehem Biophy Acta1985，833，： | 1 |
| 20 | Lipoprotein abonormalities as a risk factor for progressive nondiabetic renal disease显示文摘 | ATTMAN PO ALAUPOVIC P SAMUELSSON O | 1999 | Kidney Int1999，56，71： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员